Point72 Asset Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,040
Closed -$687K 1190
2021
Q4
$687K Buy
+1,040
New +$795K ﹤0.01% 944
2020
Q4
Sell
-2,242
Closed -$1.58M 925
2020
Q3
$1.58M Buy
+2,242
New +$1.63M 0.01% 729

Other funds holding CDLX

Point72 Asset Management's CDLX Position: Q1 2022 in Review

Point72 Asset Management sold out of Cardlytics (CDLX) in Q1 2022, closing a stake of 1,040 shares — an estimated $687K sold.

Point72 Asset Management first reported a position in CDLX in Q3 2020 and held it in 2 quarters. The position peaked at $1.58M in Q3 2020. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.

  • Point72 Asset Management reported no remaining Cardlytics position as of Q1 2022 after selling out during the quarter.
  • Point72 Asset Management sold 1,040 Cardlytics shares in Q1 2022, an estimated $687K.
  • Point72 Asset Management first reported a position in Cardlytics in Q3 2020 and held it in 2 quarters.
  • Point72 Asset Management's Cardlytics position peaked at $1.58M in Q3 2020.
  • 153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.

Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.